ICARA study: Bapineuzumab

Here is a great dementia resource for caregivers and healthcare professinals,

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Here are more interesting dementia brain boosting activities





Get your subscription to Activity Director Today's e magazine

The goal of the ICARA (Bapi) study is to determine if an investigational drug, called bapineuzumab, can help slow the progression of Alzheimer's disease.

Current therapies for Alzheimer's treat the symptoms associated with it, not the disease itself.

It is important for patients and families affected by Alzheimer's to consider participating in clinical studies.

A medical team, including a physician, will monitor participants throughout the study.

There is no charge to participate in this study.

To find out more about bapineuzumab